港股詳情

本頁面由Tiger Trade Technology Pte. Ltd.提供服務

銀諾醫藥-B

26.840

-0.100-0.37%

成交量：55.36萬

成交額：1,480.70萬

市值：122.66億

市盈率：-64.48

高：27.360

開：26.900

低：25.900

收：26.940

52周最高：74.000

52周最低：25.500

股本：4.57億

香港流通股本：4.20億

量比：0.31

換手率：0.13%

股息：- -

股息率：- -

每股收益(LYR):-0.416

淨資產收益率：-23.27%

總資產收益率：-11.61%

市淨率：15.94

市盈率(LYR):-64.48

市銷率: 192.83

資料載入中...

總覽公司新聞資訊公告

概念

no data

沒有相關數據

資金流向

資金流入：

資金流出：

新聞資訊

銀諾醫藥-B(02591)：楊東妍獲委任為聯席公司秘書

港股異動 | 銀諾醫藥升逾16%，公司核心產品依蘇帕格魯肽α在寵物糖尿病管理已取得積極進展

老虎资讯综合

銀諾醫藥-B(02591)：依蘇帕格魯肽α的新獸藥臨牀試驗申請獲受理

銀諾醫藥集團新獸藥臨牀試驗申請獲農業農村部受理

{"basename":"/hant","ssrTDKData":{"titleTemplate":"%s - 老虎證券","title":"澳洲华人首选美澳港股一站式交易平台 | 老虎证券","description":"澳、美、港、A股、ETF、期权一站式在线交易，超低佣金，新手也能轻松开启投资。在老虎证券， 1 美元起投资美股，24/5 无时差交易美股，澳大利亚华人信赖的在线炒股平台。","keywords":"老虎证券,老虎证券澳洲,老虎证券股票,老虎证券开户,老虎证券app,tigertrade老虎证券,股票,asx美股,炒股,券商,澳洲股票交易,澳大利亚炒股","social":{"ogDescription":"澳、美、港、A股、ETF、期权一站式在线交易，超低佣金，新手也能轻松开启投资。在老虎证券， 1 美元起投资美股，24/5 无时差交易美股，澳大利亚华人信赖的在线炒股平台。","ogImage":"https://c1.itigergrowtha.com/portal5/static/media/og-logo.be62fbe1.png","ogUrl":"https://www.itiger.com/hant/stock/02591"},"companyName":"老虎證券"},"pageData":{"isMobile":false,"isTiger":false,"isTTM":true,"region":"AUS","license":"TBAU","edition":"fundamental","symbol":"02591","isAnalysisPage":false},"__swrFallback__":{"@#url:\"https://hq.skytigris.cn/stock_info/detail/global\",params:#delay:false,,method:\"POST\",data:#items:@#symbol:\"02591\",,,,,undefined,":{"symbol":"02591","market":"HK","secType":"STK","nameCN":"銀諾醫藥-B","latestPrice":26.84,"timestamp":1770365282568,"preClose":26.94,"halted":0,"volume":553600,"delay":0,"changeRate":-0.003711952487008219,"floatShares":420285370,"shares":457000000,"eps":-0.416279,"marketStatus":"休市中","change":-0.1,"latestTime":"02-06 16:08:02","open":26.9,"high":27.36,"low":25.9,"amount":14807020,"amplitude":0.054195,"askPrice":27,"askSize":200,"bidPrice":26.84,"bidSize":1800,"shortable":0,"etf":0,"ttmEps":-0.533,"tradingStatus":0,"nextMarketStatus":{"tag":"開盤","tradingStatus":2,"beginTime":1770600600000},"marketStatusCode":7,"adr":0,"listingDate":1755187200000,"exchange":"SEHK","adjPreClose":26.94,"openAndCloseTimeList":[[1770341400000,1770350400000],[1770354000000,1770364800000]],"volumeRatio":0.3110706539398918,"lotSize":200,"spreadScale":0,"tradeCurrency":"HKD"},"@#url:\"https://hq.skytigris.cn/stock_info/fundamental/all\",params:#delay:false,,method:\"POST\",data:#items:@#symbol:\"02591\",,,,,undefined,":{"symbol":"02591","floatShares":420285370,"roa":"-11.61%","roe":"-23.27%","lyrEps":-0.416279,"volumeRatio":0.3110706539398918,"shares":457000000,"dividePrice":0,"high":27.36,"amplitude":0.054195,"preClose":26.94,"low":25.9,"week52Low":25.5,"pbRate":"15.94","psRate":"192.83","week52High":74,"institutionHeld":0,"latestPrice":26.84,"committee":0.8,"eps":-0.416279,"divideRate":0,"volume":553600,"delay":0,"ttmEps":-0.533,"open":26.9,"prevYearClose":30.64,"prevWeekClose":29.8,"prevMonthClose":29.8,"prevQuarterClose":30.64,"fiveDayClose":29.8,"twentyDayClose":30.96,"sixtyDayClose":31.62},"@#url:\"https://hq.skytigris.cn/fundamental/corporate_actions/details/02591\",params:#limit:5,,,undefined,":[{"date":"2025-08-29","symbol":"02591","type":"earning","reportTimeType":"","market":"HK","fiscalQuarterEnding":null,"expectedEps":null,"defaultRemindTime":1756431000000,"name":null,"time":"","dateTimestamp":1756396800000,"actualEps":null}],"@#url:\"https://hq.skytigris.cn/fundamental/dividend/history\",params:#symbol:\"02591\",market:\"HK\",,,undefined,":[],"@#url:\"https://hq.skytigris.cn/fundamental/estimate/recommendation\",params:#symbol:\"02591\",market:\"HK\",delay:false,,,undefined,":{},"@#url:\"https://hq.skytigris.cn/hkstock/value_analysis/stock/02591\",params:#withQuantilePoint:true,period:\"5year\",factor:\"peRate\",delay:false,algorithm:1,,,undefined,":{"brief":{"id":"02591","date":"2026-02-06","current":-50.356473,"percent":0.991597,"low":-137.156472,"twenty":-80.235292,"median":-63.834,"eighty":-57.242442,"high":-47.228587,"avg":-71.454279,"sd":19.583403,"marketCap":12261031327},"quantilePoints":[{"date":"2025-08-15","current":-137.156472,"twenty":-137.156472,"median":-137.156472,"eighty":-137.156472,"marketCap":26152907730},{"date":"2025-08-22","current":-127.373977,"twenty":-129.344203,"median":-127.373977,"eighty":-126.417438,"marketCap":24211425497},{"date":"2025-08-29","current":-106.390102,"twenty":-127.373977,"median":-126.095992,"eighty":-114.007182,"marketCap":20319324643},{"date":"2025-09-05","current":-78.151342,"twenty":-127.373977,"median":-117.586994,"eighty":-99.491273,"marketCap":18939730209},{"date":"2025-09-12","current":-83.843855,"twenty":-126.417438,"median":-105.433356,"eighty":-83.374192,"marketCap":20355870191},{"date":"2025-09-19","current":-79.271387,"twenty":-126.095992,"median":-93.890147,"eighty":-81.90749,"marketCap":19232094592},{"date":"2025-09-26","current":-78.986763,"twenty":-125.916102,"median":-85.498552,"eighty":-79.429082,"marketCap":19113321562},{"date":"2025-10-03","current":-76.5387,"twenty":-122.116665,"median":-83.843855,"eighty":-78.76383,"marketCap":18565138343},{"date":"2025-10-10","current":-69.068341,"twenty":-116.871032,"median":-83.374192,"eighty":-77.810518,"marketCap":16728724560},{"date":"2025-10-17","current":-67.838616,"twenty":-109.436934,"median":-79.738352,"eighty":-74.826182,"marketCap":16418087403},{"date":"2025-10-24","current":-59.813644,"twenty":-105.816054,"median":-79.429082,"eighty":-68.576451,"marketCap":14481173363},{"date":"2025-10-31","current":-57.61442,"twenty":-103.460611,"median":-78.986763,"eighty":-66.346017,"marketCap":13969535692},{"date":"2025-11-07","current":-56.556997,"twenty":-100.097405,"median":-78.243448,"eighty":-63.14919,"marketCap":13704580470},{"date":"2025-11-14","current":-61.96171,"twenty":-95.010372,"median":-77.299283,"eighty":-61.326336,"marketCap":15056765743},{"date":"2025-11-21","current":-54.467459,"twenty":-87.179427,"median":-75.823033,"eighty":-60.1184,"marketCap":13229488347},{"date":"2025-11-28","current":-82.342484,"twenty":-85.508442,"median":-76.5387,"eighty":-60.703449,"marketCap":20072642195},{"date":"2025-12-05","current":-82.313405,"twenty":-85.248884,"median":-75.823033,"eighty":-61.326336,"marketCap":20100051356},{"date":"2025-12-12","current":-63.824496,"twenty":-84.462171,"median":-74.404407,"eighty":-61.326336,"marketCap":15614085348},{"date":"2025-12-19","current":-62.072323,"twenty":-83.725798,"median":-74.049705,"eighty":-60.286674,"marketCap":15221220708},{"date":"2025-12-24","current":-59.762449,"twenty":-83.548712,"median":-73.276127,"eighty":-59.816947,"marketCap":14700446650},{"date":"2026-01-02","current":-56.27243,"twenty":-83.409096,"median":-71.366231,"eighty":-59.572219,"marketCap":13896444596},{"date":"2026-01-09","current":-57.1291,"twenty":-82.548826,"median":-69.803372,"eighty":-58.239982,"marketCap":14143127045},{"date":"2026-01-16","current":-56.980838,"twenty":-82.319221,"median":-67.499105,"eighty":-57.682607,"marketCap":14152263432},{"date":"2026-01-23","current":-58.213825,"twenty":-82.096799,"median":-66.291021,"eighty":-57.601428,"marketCap":14444627815},{"date":"2026-01-30","current":-54.613459,"twenty":-81.934522,"median":-64.906051,"eighty":-57.510573,"marketCap":13613216600},{"date":"2026-02-06","current":-49.064319,"twenty":-80.235292,"median":-63.834,"eighty":-57.242442,"marketCap":12261031327}],"updateTime":1770435135438},"$inf$@#url:\"https://stock-news.skytigris.cn/v2/news/list\",params:#symbols:\"02591\",pageSize:4,pageCount:1,lang_content:\"cn\",edition:\"fundamental\",,,undefined,":[{"items":[{"id":"2609563048","title":"銀諾醫藥-B(02591)：楊東妍獲委任為聯席公司秘書","url":"https://stock-news.laohu8.com/highlight/detail?id=2609563048","media":"智通财经","labels":["executive"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2609563048?lang=zh_tw&edition=fundamental","pubTime":"2026-02-06 16:41","pubTimestamp":1770367311,"startTime":"0","endTime":"0","summary":"智通财经APP讯，银诺医药-B(02591)发布公告，金今女士因个人发展原因辞任公司联席公司秘书，自2026年2月6日起生效。杨东妍女士已获委任为联席公司秘书，自2026年2月6日起生效。杨女士将与另一名现任联席公司秘书施雪玲女士共同履行公司秘书职务。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://www.zhitongcaijing.com/content/detail/1402535.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"executive","news_rank":0,"length":0,"strategy_id":0,"source":"stock_zhitongcaijing","symbols":["02591","BK1161"],"gpt_icon":0},{"id":"1140982312","title":"港股異動 | 銀諾醫藥升逾16%，公司核心產品依蘇帕格魯肽α在寵物糖尿病管理已取得積極進展","url":"https://stock-news.laohu8.com/highlight/detail?id=1140982312","media":"老虎资讯综合","labels":["productRelease"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/1140982312?lang=zh_tw&edition=fundamental","pubTime":"2026-02-05 09:51","pubTimestamp":1770256294,"startTime":"0","endTime":"0","summary":"2月5日，$银诺医药-B$涨超16%，公司核心产品依苏帕格鲁肽α在宠物糖尿病管理已取得积极进展。消息面上，银诺医药-B发布公告，于2026年2月4日，公司核心产品依苏帕格鲁肽α用于治疗宠物糖尿病的新兽药临床试验申请已获中华人民共和国农业农村部正式受理。根据临床前试验结果，就疗效和安全性而言，依苏帕格鲁肽α在宠物糖尿病管理方面已取得积极进展，可为后续开展该药物相关的临床试验和注册申请提供合理依据。","market":"hk","thumbnail":"https://static.tigerbbs.com/6ad7ed6b96b448ffcc5b5501b0dc346c","type":0,"news_type":0,"thumbnails":["https://static.tigerbbs.com/6ad7ed6b96b448ffcc5b5501b0dc346c"],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":"059ce91f94e1e421008ab9104b6318dc","theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":true,"source_rank":0,"column":"","sentiment":"2","news_top_title":null,"news_tag":"productRelease","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK1161","02591"],"gpt_icon":0},{"id":"2608636075","title":"銀諾醫藥-B(02591)：依蘇帕格魯肽α的新獸藥臨牀試驗申請獲受理","url":"https://stock-news.laohu8.com/highlight/detail?id=2608636075","media":"智通财经","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2608636075?lang=zh_tw&edition=fundamental","pubTime":"2026-02-04 22:20","pubTimestamp":1770214850,"startTime":"0","endTime":"0","summary":"智通财经APP讯，银诺医药-B 发布公告，于2026年2月4日，公司核心产品依苏帕格鲁肽α用于治疗宠物糖尿病的新兽药临床试验申请已获中华人民共和国农业农村部正式受理。预计将于2026年第一季度开始I期临床试验。根据临床前试验结果，就疗效和安全性而言，依苏帕格鲁肽α在宠物糖尿病管理方面已取得积极进展，可为后续开展该药物相关的临床试验和注册申请提供合理依据。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://www.zhitongcaijing.com/content/detail/1401776.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stock_zhitongcaijing","symbols":["02591","BK1161"],"gpt_icon":0},{"id":"1122862815","title":"銀諾醫藥集團新獸藥臨牀試驗申請獲農業農村部受理","url":"https://stock-news.laohu8.com/highlight/detail?id=1122862815","media":"美股速递","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/1122862815?lang=zh_tw&edition=fundamental","pubTime":"2026-02-04 22:18","pubTimestamp":1770214693,"startTime":"0","endTime":"0","summary":"广州银诺医药集团有限公司宣布，其提交的一项新型兽用药品临床试验申请已获得农业农村部正式受理。该进展标志着公司在兽药研发领域取得重要突破，为后续产品管线拓展奠定基础。","market":"us","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":"","theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["02591","BK1161"],"gpt_icon":0}],"pageSize":4,"totalPage":37,"pageCount":1,"totalSize":147,"code":"91000000","status":"200"}],"@#url:\"https://hq.skytigris.cn/market/plate/belongs/02591\",params:#limit:6,delay:false,,,undefined,":[]}}